Overview

Vascular and Metabolic Effects of Vytorin vs Simvastatin

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
0
Participant gender:
All
Summary
The investigators hypothesize that vytorin will improve insulin resistance compared with simvastatin
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Gachon University Gil Medical Center
Treatments:
Ezetimibe, Simvastatin Drug Combination
Simvastatin
Criteria
Inclusion Criteria:

- hypercholesterolemic patients (LDL cholesterol levels>100 mg/dl)

Exclusion Criteria:

- overt liver disease, chronic renal failure, hypothyroidism, myopathy, uncontrolled
diabetes (HbA1c > 9%), severe hypertension, stroke, acute coronary events, coronary
revascularization within the preceding 3 months, or alcohol abuse